Impaired Social and Role Function in Ultra-High Risk for Psychosis and First-Episode Schizophrenia: Its Relations with Negative Symptoms

So Jung Lee, Kyung Ran Kim, Su Young Lee, Suk Kyoon An, So Jung Lee, Kyung Ran Kim, Su Young Lee, Suk Kyoon An

Abstract

Objective: Psychosocial dysfunction was a nettlesome of schizophrenia even in their prodromal phase as well as first episode and its relations with psychopathology were not determined. The aim of the present study was to examine whether the social and role function impairment was found in ultra-high risk for psychosis (UHR) individuals as well as first-episode schizophrenia patients and to explore its relations with psychopathology.

Methods: Thirty-seven normal controls, 63 UHR participants and 28 young, first-episode schizophrenia patients were recruited. Psychosocial functioning was examined by using Global function: Social and Role scale. Psychopathologies of positive, negative and depressive symptom were also measured.

Results: Social and role functioning in UHR were compromised at the equivalent level of those of first-episode schizophrenia patients. Multiple linear regression analysis revealed that social and role dysfunction was associated with negative symptoms in each UHR and first-episode schizophrenia group.

Conclusion: These findings suggest that the significant impairment of social and role function may be appeared before the active psychosis onset at the level of extent to those of first-episode schizophrenia patients. The psychosocial intervention strategy especially targeting the negative symptoms should be developed and provided to individuals from their prepsychotic stage of schizophrenia.

Keywords: First episode; Role dysfunction; Schizophrenia; Social dysfunction; Ultra-high risk.

References

    1. American Psychiatric Association. DSM-5: Diagnostic and Statistical Manual of Mental Disorders. 5th Edition. Washington, DC: American Psychiatric Publishing; 2013.
    1. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, et al. Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr Res. 2003;60:21–32.
    1. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: Psychopathology and clinical features. Schizophr Res. 2004;67:131–142.
    1. Velthorst E, Nelson B, Wiltink S, de Haan L, Wood SJ, Lin A, et al. Transition to first episode psychosis in ultra high risk populations: does baseline functioning hold the key? Schizophr Res. 2013;143:132–137.
    1. Valmaggia LR, Stahl D, Yung AR, Nelson B, Fusar-Poli P, McGorry PD, et al. Negative psychotic symptoms and impaired role functioning predict transition outcomes in the at-risk mental state: a latent class cluster analysis study. Psychol Med. 2013;43:2311–2325.
    1. Addington J, van Mastrigt S, Addington D. Patterns of premorbid functioning in first-episode psychosis: initial presentation. Schizophr Res. 2003;62:23–30.
    1. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry. 2005;10:434–449.
    1. Addington J, Penn D, Woods SW, Addington D, Perkins DO. Social functioning in individuals at clinical high-risk for psychosis. Schizophr Res. 2008;99:119–124.
    1. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008;65:28–37.
    1. Perlick DA, Rosenheck RA, Kaczynski R, Bingham S, Collins J. Association of symptomatology and cognitive deficits to functional capacity in schizophrenia. Schizophr Res. 2008;99:192–199.
    1. Yamauchi K, Aki H, Tomotake M, Iga J, Numata S, Motoki I, et al. Predictors of subjective and objective quality of life in outpatients with schizophrenia. Psychiatry Clin Neurosci. 2008;62:404–411.
    1. Woon PS, Chia MY, Chan WY, Sim K. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:463–468.
    1. Narvaez JM, Twamley EW, McKibbin CL, Heaton RK, Patterson TL. Subjective and objective quality of life in schizophrenia. Schizophr Res. 2008;98:201–208.
    1. Mohamed S, Rosenheck R, Swartz M, Stroup S, Lieberman JA, Keefe RS. Relationship of cognition and psychopathology to functional impairment in schizophrenia. Am J Psychiatry. 2008;165:978–987.
    1. Stouten LH, Veling W, Laan W, van der Helm M, van der Gaag M. Psychotic symptoms, cognition and affect as predictors of psychosocial problems and functional change in first-episode psychosis. Schizophr Res. 2014;158:113–119.
    1. Strauss GP, Sandt AR, Catalano LT, Allen DN. Negative symptoms and depression predict lower psychological well-being in individuals with schizophrenia. Compr Psychiatry. 2012;53:1137–1144.
    1. Rabinowitz J, Levine SZ, Garibaldi G, Bugarski-Kirola D, Berardo CG, Kapur S. Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data. Schizophr Res. 2012;137:147–150.
    1. Hunter R, Barry S. Negative symptoms and psychosocial functioning in schizophrenia: neglected but important targets for treatment. Eur Psychiatry. 2012;27:432–436.
    1. Song YY, Kim KR, Park JY, Lee SY, Kang JI, Lee E, et al. Associated factors of quality of life in first-episode schizophrenia patients. Psychiatry Investig. 2011;8:201–206.
    1. Rocca P, Bellino S, Calvarese P, Marchiaro L, Patria L, Rasetti R et al. Depressive and negative symptoms in schizophrenia: different effects on clinical features. Compr Psychiatry. 2005;46:304–310.
    1. Masillo A, Valmaggia LR, Saba R, Brandizzi M, Lindau JF, Solfanelli A, et al. Interpersonal sensitivity and functioning impairment in youth at ultra-high risk for psychosis. Eur Child Adolesc Psychiatry. 2016;25:7–16.
    1. Svirskis T, Korkeila J, Heinimaa M, Huttunen J, Ilonen T, Ristkari T, et al. Quality of life and functioning ability in subjects vulnerable to psychosis. Compr Psychiatry. 2007;48:155–160.
    1. Schlosser DA, Campellone TR, Biagianti B, Delucchi KL, Gard DE, Fulford D, et al. Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis. Schizophr Res. 2015;169:204–208.
    1. Kim KR, Song YY, Park JY, Lee EH, Lee M, Lee SY, et al. The relationship between psychosocial functioning and resilience and negative symptoms in individuals at ultra-high risk for psychosis. Aust N Z J Psychiatry. 2013;47:762–771.
    1. Corcoran CM, Kimhy D, Parrilla-Escobar MA, Cressman VL, Stanford AD, Thompson J, et al. The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychol Med. 2011;41:251–261.
    1. Ruhrmann S, Paruch J, Bechdolf A, Pukrop R, Wagner M, Berning J, et al. Reduced subjective quality of life in persons at risk for psychosis. Acta Psychiatr Scand. 2008;117:357–368.
    1. Olvet DM, Carrión RE, Auther AM, Cornblatt BA. Self-awareness of functional impairment in individuals at clinical high-risk for psychosis. Early Interv Psychiatry. 2015;9:100–107.
    1. First MB, Gibbon M, Spitzer RL, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders: Non-Patients Edition (SCID-I/NP) New York: Biometrics Research, New York State Psychiatric Institute; 2002.
    1. First MB, Gibbon M, Spitzer RL, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders: Patient Edition (SCID-I/P) New York: Biometrics Research, New York State Psychiatric Institute; 2002.
    1. McGlashan TH, Miller TJ, Woods SW. Structured Interview for Prodromal Syndromes (SIPS), Version 4.0. New Heaven: Yale University; 2003.
    1. Auther AM, Smith CW, Cornblatt BA. Global functioning: Social Scale (GF: Social) Glen Oaks, NY: Zucker-Hillside Hospital; 2006.
    1. Niendam TA, Bearden CE, Johnson JK, Cannon TD. Global functioning: Role Scale (GF: Role) Los Angeles, CA: University of California, Los Angeles; 2006.
    1. Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS) Iowa City: University of Iowa; 1983.
    1. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS) Iowa City: University of Iowa; 1983.
    1. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389.
    1. Mattila-Evenden M, Svanborg P, Gustavsson P, Åsberg M. Determinants of self-rating and expert rating concordance in psychiatric out-patients, using the affective subscales of the CPRS. Acta Psychiatr Scand. 1996;94:386–396.
    1. Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition into psychosis. Schizophr Bull. 2014;40:120–131.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner